Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission

SK Sarin, M Kumar, M Eslam, J George… - The lancet …, 2020 - thelancet.com
Summary The Asia-Pacific region is home to more than half of the global population and
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …

Systematic review of disparities in surgical care for Māori in New Zealand

JL Rahiri, Z Alexander, M Harwood… - ANZ journal of …, 2018 - Wiley Online Library
Background Health equity for Indigenous peoples in the context of surgery has recently
become topical amongst surgeons in Australasia. Health inequities are amongst the most …

Disparities in Cancer-specific survival between Māori and non-Māori New Zealanders, 2007-2016

J Gurney, J Stanley, M McLeod, J Koea… - JCO Global …, 2020 - ascopubs.org
PURPOSE While cancer survival is improving across most developed nations, those
improvements are not shared equally within their population. Using high-quality national …

Equity of travel required to access first definitive surgery for liver or stomach cancer in New Zealand

J Gurney, J Whitehead, C Kerrison, J Stanley, D Sarfati… - Plos one, 2022 - journals.plos.org
In New Zealand, there are known disparities between the Indigenous Māori and the majority
non-Indigenous European populations in access to cancer treatment, with resulting …

Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis

C Zhao, F Xing, YH Yeo, M Jin, R Le, M Le… - European journal of …, 2020 - journals.lww.com
Methods We included original research articles of studies of patients already diagnosed with
hepatocellular carcinoma that reported the proportion of hepatocellular carcinoma …

Expression analysis of MicroRNA-21 and MicroRNA-122 in hepatocellular carcinoma

D Bharali, BD Banerjee, M Bharadwaj… - Journal of clinical and …, 2019 - Elsevier
Background/objective Hepatocellular carcinoma (HCC) is a multistep process starting from
chronic hepatitis (CH) that progress through cirrhosis to HCC. The expression level of …

[HTML][HTML] Expression analysis of serum microRNA-34a and microRNA-183 in hepatocellular carcinoma

D Bharali, HB Jebur, D Baishya, S Kumar… - Asian Pacific journal …, 2018 - ncbi.nlm.nih.gov
Methods: Real time quantitative PCR was done to find out the miRNA expression level in
terms of Ct value followed by statistical analysis. Results: Over-expression of miR-183 and …

[PDF][PDF] Equity by 2030: achieving equity in survival for Māori cancer patients.

J Gurney, S Campbell, C Jackson… - Cancer survival equity …, 2019 - academia.edu
ABSTRACT Māori diagnosed with cancer are more likely to die—and to die sooner—than
non-Māori with cancer. If we accept that these inequities are unfair and avoidable, then we …

[PDF][PDF] Stage at diagnosis for Māori cancer patients: disparities, similarities and data limitations

J Gurney, J Stanley, C Jackson, D Sarfati - NZ Med J, 2020 - nzmj.org.nz
ABSTRACT Māori are more likely than non-Māori to get cancer, and once they have cancer
they are less likely to survive it. One frequently proposed explanation for this survival …

Expansion of liver transplantation criteria for hepatocellular carcinoma from Milan to UCSF in Australia and New Zealand and justification for Metroticket 2.0

SG Barreto, SI Strasser, GW McCaughan, MA Fink… - Cancers, 2022 - mdpi.com
Simple Summary Liver transplantation (LT) is considered the only curative therapeutic
option for early, unresectable, and unablatable hepatocellular carcinoma (HCC), particularly …